Skip to main content
logo
Vaxil Bio Ltd. (TSXV:VXL)
Canada flag Canada · Delayed Price · Currency is CAD
0.1450
-0.0050 (-3.33%)
At close: Sep 15, 2026

Vaxil Bio Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1113310
Market Cap Growth
28.32%-57.83%-60.00%25.00%-73.33%-70.43%
Enterprise Value
001218
Last Close Price
0.150.140.501.251.003.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.381.11----
PB Ratio
0.500.421.913.842.416.04
P/TBV Ratio
0.500.421.913.842.416.04

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.39-0.49-0.63-1.05-1.33-1.32
Net Debt / EBITDA Ratio
---3.722.602.32
Quick Ratio
17.97134.8026.7711.263.783.89
Current Ratio
17.97137.0043.1211.483.813.90
Return on Equity (ROE)
39.89%50.07%-16.18%-25.06%-41.19%-78.75%
Return on Assets (ROA)
-16.59%-10.64%-10.82%-12.61%-19.08%-31.23%
Return on Capital Employed (ROCE)
-21.40%-13.10%-20.70%-28.50%-51.40%-58.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
63.42%90.36%-13.00%-7.42%-21.32%-9.60%
Buyback Yield / Dilution
-26.20%-3.48%---0.64%-33.78%